As an epigenetic regulator, EZH2 is highly expressed in a variety of malignant tumors and associated with poor prognosis of tumors including colorectal cancer,bladder cancer, non-small cell lung cancer 27-29. This evidence concerns the gene EZH2 and non-small cell lung carcinoma.